FIM study

2018-01-07 01:23

We have succesfully finished our first First in Man study with psychoactive, anti-depressive substance, which is expected to be a breakthrough in depression treatment.

The study is conducted for one of the most promising Polish phramaceutical companies, as a part of NCBiR programme.

Go back

News

2018-03-10 10:17

First phase study

We have just succesfully finished the second part of the first phase study with no Serious Adverse Events.

Bioequivalence study

We have just finished clinical part of one of our ongoing bioequivalence Clinical Studies.

Membership in SCRS

We have joined the Society for Clinical Research Sites (SCRS)!

Open Recruitment to new study

We have started new study with testosterone for healthy Volunteers or Patients with testosterone deficiency.

2018-01-07 01:23

FIM study

We have just succesfully finished First in Man study with psychoactive substance.